Diabetic Neuropathies Clinical Trials

16 recruiting

Diabetic Neuropathies Trials at a Glance

17 actively recruiting trials for diabetic neuropathies are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Bahawalpur, Bilecik, and Cairo. Lead sponsors running diabetic neuropathies studies include Cairo University, C5 Biomedical, and Bilecik Seyh Edebali Universitesi.

Browse diabetic neuropathies trials by phase

Treatments under study

About Diabetic Neuropathies Clinical Trials

Looking for clinical trials for Diabetic Neuropathies? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetic Neuropathies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetic Neuropathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 1Phase 2

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
Florida A&M University20 enrolled1 locationNCT07298408
Recruiting
Early Phase 1

Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain

Diabetic FootDiabetic Peripheral NeuropathyDiabetic Neuropathies, Painful
Carilion Clinic80 enrolled1 locationNCT07260656
Recruiting
Not Applicable

Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

Cardiovascular DiseasesOsteoporosisType 2 Diabetes+2 more
Aalborg University Hospital490 enrolled1 locationNCT06745544
Recruiting
Not Applicable

Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

Diabetes MellitusDiabetic Neuropathies
Khyber Medical University Peshawar80 enrolled1 locationNCT07425275
Recruiting
Not Applicable

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Diabetes MellitusPeripheral Arterial DiseaseAnemia+6 more
Heinrich-Heine University, Duesseldorf200 enrolled1 locationNCT06124586
Recruiting

Neuropathic Pain and Type II Diabetic Patients

Quality of LifeNeuropathic PainDiabetic Neuropathies
Bilecik Seyh Edebali Universitesi128 enrolled1 locationNCT06798181
Recruiting

Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

Diabetic NeuropathiesDiabetic Peripheral Neuropathy
Cairo University290 enrolled1 locationNCT06483620
Recruiting
Phase 1Phase 2

Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

Diabetic Neuropathies
University of Iowa100 enrolled2 locationsNCT05169060
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting
Phase 2

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Type 2 DiabetesDiabetic NeuropathiesCardiovascular Autonomic Neuropathy
Peter Rossing100 enrolled2 locationsNCT06906081
Recruiting
Not Applicable

Additional Hyperbaric Oxygen After Lower Extremity Amputation

OsteomyelitisDiabetes MellitusAmputation+6 more
Oslo University Hospital120 enrolled2 locationsNCT03594344
Recruiting
Not Applicable

Effects of Customized Silicone Digital Orthoses in People With Diabetic Neuropathy

Diabetic Neuropathies
University of Sao Paulo General Hospital60 enrolled1 locationNCT05683106
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting
Not Applicable

MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts

NeuropathyAmputationDiabetic Neuropathies+2 more
ETH Zurich40 enrolled1 locationNCT05483816
Recruiting
Not Applicable

Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy

Diabetic Neuropathies
Cairo University60 enrolled1 locationNCT06670430
Recruiting
Not Applicable

US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot

Diabetic FootDiabetic Neuropathies
Riphah International University46 enrolled1 locationNCT06479577
Recruiting
Not Applicable

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

Diabetes Mellitus, Type 2Obstructive Sleep ApneaObesity, Morbid+3 more
Steno Diabetes Center Greenland1,000 enrolled1 locationNCT06264427